Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Federico, Chiurazzi"'
Autor:
Rosa Catapano, Leandra Sepe, Elvira Toscano, Giovanni Paolella, Federico Chiurazzi, Serafina Patrizia Barbato, Dario Bruzzese, Rosa Arianna, Michela Grosso, Simona Romano, Maria Fiammetta Romano, Paola Costanzo, Elena Cesaro
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Chronic lymphocytic leukemia (CLL) is a heterogeneous disease, whose presentation and clinical course are highly variable. Identification of novel prognostic factors may contribute to improving the CLL classification and providing indications for tre
Externí odkaz:
https://doaj.org/article/6f077d505abb49978b900d30ccd4ebb5
Autor:
Mariano Fiorenza, Michele Cennamo, Evelina La Civita, Stefano Brusa, Luca Vallefuoco, Rosanna Sorrentino, Giuseppe Gaeta, Federico Chiurazzi, Elena Grimaldi, Massimiliano Galdiero, Daniela Terracciano, Giuseppe Portella
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 7, Iss , Pp 100178- (2022)
Heterophilic antibodies can interfere with laboratory tests causing erroneous results. We report the case of a 55-year-old man with Mantle cell myeloma treated with Rituximab that caused false positive results of HIV serologic test. The cause of this
Externí odkaz:
https://doaj.org/article/2bee2ae627c94cde9788ec7eaea920bc
Autor:
Elena Cesaro, Andrea Patrizia Falanga, Rosa Catapano, Francesca Greco, Simona Romano, Nicola Borbone, Arianna Pastore, Maria Marzano, Federico Chiurazzi, Stefano D'Errico, Gennaro Piccialli, Giorgia Oliviero, Paola Costanzo, Michela Grosso
Publikováno v:
PLoS ONE, Vol 17, Iss 3, p e0266090 (2022)
We herein report an innovative antisense approach based on Peptide Nucleic Acids (PNAs) to down-modulate CD5 expression levels in chronic lymphocytic leukemia (CLL). Using bioinformatics tools, we selected a 12-mer tract of the CD5 mRNA as the molecu
Externí odkaz:
https://doaj.org/article/d1f9f64d848b44629e8a5580a31483b0
Autor:
Monica Carpenedo, Erminia Baldacci, Claudia Baratè, Alessandra Borchiellini, Francesco Buccisano, Giuseppina Calvaruso, Federico Chiurazzi, Bruno Fattizzo, Gaetano Giuffrida, Elena Rossi, Francesca Palandri, Potito Rosario Scalzulli, Sergio Mario Siragusa, Angelantonio Vitucci, Francesco Zaja
Publikováno v:
Therapeutic Advances in Hematology, Vol 12 (2021)
Introduction: In patients with primary immune thrombocytopenia (ITP), a short course of steroids is routinely given as first-line therapy. However, the response is often transient and additional therapy is usually needed. Thrombopoietin receptor agon
Externí odkaz:
https://doaj.org/article/f778d6c8959641f2847bc57d4ee14356
Autor:
Domenico Maisano, Enrico Iaccino, Alessandro D’Ambrosio, Federico Chiurazzi, Vincenzo Dattilo, Mariangela Scalise, Massimo Gentile, Eleonora Vecchio, Nancy Nisticò, Annamaria Aloisio, Erika De Sensi, Giuseppe Fiume, Ileana Quinto, Selena Mimmi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The immunoglobulin B cell receptor (IgBCR) expressed by chronic lymphocytic leukemia (CLL) B cells plays a pivotal role in tumorigenesis, supporting neoplastic transformation, survival, and expansion of tumor clones. We demonstrated that in the same
Externí odkaz:
https://doaj.org/article/66a5105299b3492f936bd634386336e7
Autor:
Selena Mimmi, Domenico Maisano, Vincenzo Dattilo, Massimo Gentile, Federico Chiurazzi, Alessandro D’Ambrosio, Annamaria Zimbo, Nancy Nisticò, Annamaria Aloisio, Eleonora Vecchio, Giuseppe Fiume, Enrico Iaccino, Ileana Quinto
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 604 (2022)
Chronic Lymphocytic Leukemia (CLL) is a heterogeneous disease characterized by variable clinical courses among different patients. This notion was supported by the possible coexistence of two or more independent CLL clones within the same patients, i
Externí odkaz:
https://doaj.org/article/97bf20c8ef20425f993dfd604efbd2ee
Autor:
Terrazzano, Valentina Rubino, Flavia Carriero, Anna Teresa Palatucci, Angela Giovazzino, Stefania Leone, Valerio Nicolella, Martina Calabrò, Rosangela Montanaro, Vincenzo Brancaleone, Fabrizio Pane, Federico Chiurazzi, Giuseppina Ruggiero, Giuseppe
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 11; Pages: 9596
Chronic lymphocytic leukaemia (CLL) is characterised by the expansion of a neoplastic mature B cell clone. CLL clinical outcome is very heterogeneous, with some subjects never requiring therapy and some showing an aggressive disease. Genetic and epig
Autor:
Vittoria Gammaldi, Martina Pucci, Luca Mocerino, Raffaella Iannotta, Maria Luisa Giannattasio, Benedetta Tartaglia, Velia Iadevaia, Carmine Fierarossa, Federico Chiurazzi, Roberta Esposito
Publikováno v:
European Heart Journal Supplements. 24
Background Ibrutinib is a Bruton tyrosine kinase inhibitor, approved in the last few years for treatment as primary option for all subsets of chronic lymphocytic leukemia (CLL). Its use is associated with increased incidence of atrial fibrillation (A
Autor:
null Laura Ballotta, null Monica Maccaferri, null Lorenzo De Paoli, null Lorella Orsucci, null Daniela Gottardi, null Federico Chiurazzi, null Gianluigi Reda, null Riccardo Moia, null Antonio Cuneo, null Robin Foà, null Roberto Marasca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1af552d99816e03ae830e832c2a26c1
https://doi.org/10.1002/hon.3047/v2/response1
https://doi.org/10.1002/hon.3047/v2/response1
Autor:
Nancy Nisticò, Selena Mimmi, Giuseppe Fiume, Marialuigia Iannalfo, Eleonora Vecchio, Alessandro D’Ambrosio, Domenico Augusto Francesco Maisano, Federico Chiurazzi, Enrico Iaccino, Ileana Quinto, Katia Ferrara
Publikováno v:
Leukemia